![Joseph Meidling](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joseph Meidling
Directeur Technique/Scientifique/R&D chez
CYTODYN INC.
Profil
Mr. Joseph Meidling is a Senior Director-Clinical Operations at CytoDyn, Inc. Mr. Meidling was previously employed as a Director-Clinical Pharmacology & Translational Med by Merck & Co., Inc. He received his undergraduate degree from New Jersey Institute of Technology and an MBA from Montclair State University.
Postes actifs de Joseph Meidling
| Sociétés | Poste | Début |
|---|---|---|
| CYTODYN INC. | Directeur Technique/Scientifique/R&D | 01/05/2022 |
Anciens postes connus de Joseph Meidling
| Sociétés | Poste | Fin |
|---|---|---|
| MERCK & CO., INC. | Corporate Officer/Principal | - |
Formation de Joseph Meidling
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
4
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
CytoDyn, Inc.
 CytoDyn, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and commercializes pharmaceutical products to treat human immunodeficiency virus infection | Health Technology |
Montclair State University
 Montclair State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New Jersey Institute of Technology
 New Jersey Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
